๐๐ฎ๐ซ๐จ๐ฉ๐'๐ฌ ๐ง๐๐ฐ ๐ฉ๐ฅ๐๐ญ๐๐จ๐ซ๐ฆ ๐ญ๐จ ๐ก๐๐ฅ๐ฉ ๐ฎ๐ง๐ฅ๐จ๐๐ค ๐๐ฎ๐ง๐๐ข๐ง๐ ๐๐จ๐ซ ๐ ๐๐ข๐จ-๐๐๐ฌ๐๐ ๐๐ฎ๐ญ๐ฎ๐ซ๐
A new Bioeconomy Investment Group is being set up to help Europe’s sustainable industries secure the funding they need to grow. The group aims to reduce financial risks for investors, create clear funding standards, and bring together public and private money.
Despite already supporting 17 million jobs and generating up to €2.7 trillion in economic value, many innovative bio-based projects struggle to secure financing at critical stages, such as moving from small-scale testing to full industrial production. This funding gap risks holding back Europe’s ability to turn scientific breakthroughs in biotechnology and sustainable materials into real-world industries.
To fix this, the European Commission and the Circular Bio-based Europe Joint Undertaking (CBE JU) have brought together European banks, national promotional institutions, venture capital funds and institutional investors to create the Bioeconomy Investment Deployment Group (BIDG).
This week’s event in Brussels formally launched the process leading to the Deployment Group’s first plenary in June 2026 and the submission of its 2026–2029 work plan to the CBE JU Governing Board.
Instead of just talking about solutions, the BIDG will focus on four key areas that match the funding process:
1. Designing better financing instruments. The work will be on blended-finance architectures, risk-sharing facilities and guarantee instruments tailored to long-duration bio-based projects. It will feed directly into the design of future EU financing frameworks, including instruments under the European Competitiveness Fund, Scale Up Fund and other EU funding instruments.
2. Building a bankable project pipeline. The Deployment Group will develop a common understanding of project bankability aspects, shared due diligence standards, and governance for a database of investment-ready projects. The objective is to shorten origination cycles and enable the formation of financing consortia for large-ticket first-of-a-kind deployments.
3. Improve transparency by monitoring and reporting. The work will include a digital eligibility checker aligned with existing sustainability and taxonomy frameworks, together with methodologies for tracking capital flows into the sector, addressing a persistent data gap that has hindered portfolio construction and benchmarking.
4. Connecting industry and investors. Linking bio-based scale-ups with financial institutions and corporates matched by ticket size, risk appetite and sectoral focus will be the focus of the workstream.
source : European Commission

Comments
Post a Comment